Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73,847 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.
Mao Y, Ma S, Liu C, Liu X, Su M, Li D, Li Y, Chen G, Chen J, Chen J, Zhao J, Guo X, Tang J, Zhuge Y, Xie Q, Xie W, Lai R, Cai D, Cai Q, Zhi Y, Li X; Technology Committee on DILI Prevention, Management, Chinese Medical Biotechnology Association; Study Group on Drug-Induced Liver Disease, Chinese Society of Hepatology, Chinese Medical Association. Mao Y, et al. Among authors: liu x, liu c. Hepatol Int. 2024 Apr;18(2):384-419. doi: 10.1007/s12072-023-10633-7. Epub 2024 Feb 24. Hepatol Int. 2024. PMID: 38402364
Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration.
Xiao X, Tang J, Mao Y, Li X, Wang J, Liu C, Sun K, Ye Y, Zou Z, Peng C, Yang L, Guo Y, Bai Z, He T, Jing J, Li F, An N. Xiao X, et al. Among authors: liu c. Acta Pharm Sin B. 2019 May;9(3):648-658. doi: 10.1016/j.apsb.2018.12.003. Epub 2018 Dec 14. Acta Pharm Sin B. 2019. PMID: 31193760 Free PMC article. No abstract available.
Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial.
Zhao ZM, Zhu CW, Huang JQ, Li XD, Zhang YX, Liang J, Zhang W, Zhang Y, Jiang XG, Zong YL, Zhang KJ, Sun KW, Zhang B, Lv YH, Xing HC, Xie Q, Liu P, Liu CH. Zhao ZM, et al. J Ethnopharmacol. 2022 Nov 15;298:115599. doi: 10.1016/j.jep.2022.115599. Epub 2022 Aug 4. J Ethnopharmacol. 2022. PMID: 35932973 Free article.
The treatment of liver fibrosis.
Liu CH. Liu CH. Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):573-5. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23227532 No abstract available.
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
Yang HI, Yeh ML, Wong GL, Peng CY, Chen CH, Trinh HN, Cheung KS, Xie Q, Su TH, Kozuka R, Lee DH, Ogawa E, Zhao C, Ning HB, Huang R, Li J, Zhang JQ, Ide T, Xing H, Iwane S, Takahashi H, Wong C, Wong C, Lin CH, Hoang J, Le A, Henry L, Toyoda H, Ueno Y, Gane EJ, Eguchi Y, Kurosaki M, Wu C, Liu C, Shang J, Furusyo N, Enomoto M, Kao JH, Yuen MF, Yu ML, Nguyen MH. Yang HI, et al. Among authors: liu c. J Infect Dis. 2020 Jan 14;221(3):389-399. doi: 10.1093/infdis/jiz477. J Infect Dis. 2020. PMID: 31550363
73,847 results
You have reached the last available page of results. Please see the User Guide for more information.